WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 555913
CAS#: 1403859-14-2 (free base)
Description: CC-90001 is a potent and selective JNK inhibitor, which is 12.9-fold more potent for JNK1 inhibition than JNK2 in a cell-based model. CC90001 currently under clinical trials for the Treatment of Idiopathic Pulmonary Fibrosis.
MedKoo Cat#: 555913
Name: CC90001 free base
CAS#: 1403859-14-2 (free base)
Chemical Formula: C16H27N5O2
Exact Mass: 321.2165
Molecular Weight: 321.425
Elemental Analysis: C, 59.79; H, 8.47; N, 21.79; O, 9.96
CC-90001 is in stock.
Related CAS #: 1946833-77-7 (HCl) 1403859-14-2 (free base) 1946833-89-1 (tosylate) 1946833-91-5 (mesylate) 1946833-97-1 (tartarte) 1946833-81-3 (lactate) 1946833-85-7 (citrate) 1946833-97-1 (fumarate)
Synonym: CC-90001; CC 90001; CC90001;
IUPAC/Chemical Name: 2-[(1,1-Dimethylethyl)amino]-4-[[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino]-5-pyrimidinecarboxamide
InChi Key: InChI=1S/C16H27N5O2/c1-9-5-6-10(7-12(9)22)19-14-11(13(17)23)8-18-15(20-14)21-16(2,3)4/h8-10,12,22H,5-7H2,1-4H3,(H2,17,23)(H2,18,19,20,21)/t9-,10-,12-/m1/s1
InChi Code: InChI=1S/C16H27N5O2/c1-9-5-6-10(7-12(9)22)19-14-11(13(17)23)8-18-15(20-14)21-16(2,3)4/h8-10,12,22H,5-7H2,1-4H3,(H2,17,23)(H2,18,19,20,21)/t9-,10-,12-/m1/s1
SMILES Code: O=C(C1=CN=C(NC(C)(C)C)N=C1N[C@H]2C[C@@H](O)[C@H](C)CC2)N
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
Soluble in DMSO | 100.0 |
The following data is based on the product molecular weight 321.425 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
van der Velden JL, Alcorn JF, Chapman DG, Lundblad LKA, Irvin CG, Davis RJ, Butnor K, Janssen-Heininger YMW. Airway epithelial specific deletion of Jun-N-terminal kinase 1 attenuates pulmonary fibrosis in two independent mouse models. PLoS One. 2020 Jan 14;15(1):e0226904. doi: 10.1371/journal.pone.0226904. PMID: 31935227; PMCID: PMC6959564.